Jennifer Lyn Herron

Exec V.P. Chief Comm'l Officer, ARIAD Pharmaceuticals.

Companies

ChemoCentryx, Inc.Board member Jun 30, 2022 to Oct 24, 2022¹
Genocea (United States)Board member Sep 28, 2021 to Sep 28, 2021²
ARIAD PharmaceuticalsExec V.P. Chief Comm'l Officer Jun 1, 2016 to Feb 16, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ChemoCentryx, Inc.0 shares⁴Oct 20, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 20, 2022Returned to company 17,237 shares of ChemoCentryx, Inc.⁴
Jun 28, 2022Granted 17,237 shares of ChemoCentryx, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARChemoCentryx, Inc., Board member
2
SEC EDGARGenocea (United States), Board member
3
SEC EDGARARIAD Pharmaceuticals, Exec V.P. Chief Comm'l Officer
4
SEC EDGARChemoCentryx, Inc. shares after the filing of Oct 20, 2022
5
SEC EDGARForm 4 filed Jun 30, 2022